Taiyo Considers Generics Collaboration With Foreign Drug Makers
This article was originally published in PharmAsia News
Executive Summary
After Nichi-Iko and Sanofi-Aventis announced a joint venture agreement, Nagoya-based Taiyo Pharmaceutical is also considering collaborating with a foreign drug maker to expand the generics market in Japan, Senior Exec Makoto Shimada disclosed in at a May 28 press briefing